Implementation of the United Kingdom's childhood influenza national vaccination programme: A review of clinical impact and lessons learned over six influenza seasons. Issue 36 (10th August 2020)
- Record Type:
- Journal Article
- Title:
- Implementation of the United Kingdom's childhood influenza national vaccination programme: A review of clinical impact and lessons learned over six influenza seasons. Issue 36 (10th August 2020)
- Main Title:
- Implementation of the United Kingdom's childhood influenza national vaccination programme: A review of clinical impact and lessons learned over six influenza seasons
- Authors:
- Kassianos, George
MacDonald, Pauline
Aloysius, Ivan
Reynolds, Arlene - Abstract:
- Highlights: In 2013, the UK extended its National Vaccination Programme for influenza. Children were vaccinated with intranasally administered LAIV. The programme was phased in over several years to broader childhood age groups. Uptake of the childhood vaccination programme has been good to excellent. The programme has had a positive impact on influenza-related outcomes. Abstract: In 2012, the Joint Committee on Vaccination and Immunisation recommended that the United Kingdom's (UK) National Vaccination Programme (NVP) for influenza was extended to include healthy children and adolescents aged 2 to <17 years. Previously, the UK's NVP focused on seasonal vaccination of the elderly and people (including children) with underlying health conditions that put them at high risk of hospitalisation if they contracted influenza. The extension of the UK's programme began in the 2013/14 influenza season through the vaccination of children aged 2–3 years in primary care across England and the devolved administrations of Scotland, Wales, and Northern Ireland. School-aged children were generally vaccinated in a school setting, with several implementation pilots in England and Scotland. Due to the scale of the programme, it has been phased in over several years and expanded to include broader childhood age groups. This article reviews the experiences from the implementation of the UK's childhood influenza NVP over the first six influenza seasons (between 2013/14 and 2018/19) from theHighlights: In 2013, the UK extended its National Vaccination Programme for influenza. Children were vaccinated with intranasally administered LAIV. The programme was phased in over several years to broader childhood age groups. Uptake of the childhood vaccination programme has been good to excellent. The programme has had a positive impact on influenza-related outcomes. Abstract: In 2012, the Joint Committee on Vaccination and Immunisation recommended that the United Kingdom's (UK) National Vaccination Programme (NVP) for influenza was extended to include healthy children and adolescents aged 2 to <17 years. Previously, the UK's NVP focused on seasonal vaccination of the elderly and people (including children) with underlying health conditions that put them at high risk of hospitalisation if they contracted influenza. The extension of the UK's programme began in the 2013/14 influenza season through the vaccination of children aged 2–3 years in primary care across England and the devolved administrations of Scotland, Wales, and Northern Ireland. School-aged children were generally vaccinated in a school setting, with several implementation pilots in England and Scotland. Due to the scale of the programme, it has been phased in over several years and expanded to include broader childhood age groups. This article reviews the experiences from the implementation of the UK's childhood influenza NVP over the first six influenza seasons (between 2013/14 and 2018/19) from the perspectives of England, Scotland, Wales, and Northern Ireland. The processes used to deliver the vaccination programme in general practice and the school-based setting are described in terms of governance, contracting, workforce management, communication, administrative tasks, vaccination sessions, vaccine supply and distribution, and surveillance. In addition, the available evidence regarding the clinical impact of the UK's childhood influenza NVP over the first six influenza seasons is reviewed. We also share lessons learned from the programme and recommendations to provide guidance to other countries looking to implement childhood influenza vaccination programmes. … (more)
- Is Part Of:
- Vaccine. Volume 38:Issue 36(2020)
- Journal:
- Vaccine
- Issue:
- Volume 38:Issue 36(2020)
- Issue Display:
- Volume 38, Issue 36 (2020)
- Year:
- 2020
- Volume:
- 38
- Issue:
- 36
- Issue Sort Value:
- 2020-0038-0036-0000
- Page Start:
- 5747
- Page End:
- 5758
- Publication Date:
- 2020-08-10
- Subjects:
- Influenza -- Vaccination -- Children -- Schools -- General practice -- United Kingdom
Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0264410X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0264410X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0264410X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.vaccine.2020.06.065 ↗
- Languages:
- English
- ISSNs:
- 0264-410X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9138.628000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13685.xml